Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Bone Neoplasms × Diagnostic Imaging × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 4 Multiple Pulmonary Nodules 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Solitary Pulmonary Nodule 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Recurrence 1 Melanoma 1 Lymphoma, Follicular 1 Lung Diseases 1 Inflammatory Bowel Diseases 1 Head and Neck Neoplasms 1 Glioma 1 Depressive Disorder, Major 1 Breast Neoplasms 1 Breast Neoplasm Female 1 Bone Neoplasms 1 Barrett Esophagus 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Ibandronic Acid 5 pembrolizumab 2 Sunitinib 2 Radiotherapy, Intensity-Modulated 2 Nivolumab 2 Methods 2 Interviews as Topic 2 Injections 2 Denosumab 2 selinexor 1 ridaforolimus 1 radium Ra 223 dichloride 1 pegfilgrastim 1 olaparib 1 montanide ISA 51 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 endostar protein 1 cc-486 1 angiotensin I (1-7) 1 Zoledronic Acid 1 Vincristine 1 Transplantation, Homologous 1 Transplantation, Autologous 1 Transcranial Direct Current Stimulation 1 Trabectedin 1 Tomography, Spiral Computed 1 TES 1 Surveys and Questionnaires 1 Standard of Care 1 Radiomics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04884048 2023-06-06

BTI-RADS M

Central Hospital, Nancy, France

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡